PT4:06 Four-year safety and efficacy of deucravacitinib in systemic lupus erythematosus: results from the phase 2 PAISLEY SLE trialCristina Arriens, Ronald F Van Vollenhoven, Marilyn C. Pike et al.|Unknown|2026Cited by 0